Current BioData will soon launch a new daily updated service assessing the impact of protein research on drug R&D.The Target Intelligence Service (TIS) is designed to gather, filter and critically evaluate the mass of information published each day about the human proteome to provide intelligence about potential drug targets for the following:

• Business Development & Licensing Executives
• Research Portfolio Managers
• Strategic Planning Executives
• Competitor Intelligence Practitioners
• Scientists at all levels engaged in Target Identification and Target Validation

TIS is used to .....

Identify possible partnering opportunities within disparate research groups

View the competitive landscape of early research in molecular and systems biology

Review the evidence available to assess the validity of a potential protein target

Assess commentary from experts on target research that will impact drug R&D

Perform due diligence on 100 days of your science & strategy

Current BioData started coverage in 2008 of all the key protein meetings that have a focus on disease and/or drug discovery, providing structured conference reports on the most important new discoveries discussed during the meetings.

The TIS Conference Reporting service will cover approximately 100 biochemistry-oriented conferences each year. The service includes daily overnight reports written "live" by Current BioData staff scientists from major conferences as they happen and specially commissioned Conference Reports by attending scientists, commenting on presentations of particular scientific or commercial interest. In both cases, reports will focus on presentations that further knowledge of the role of proteins in disease and their potential as drug targets.  

List of 2009 conferences covered by the TIS Conference Reporting Service